文献速递造血干细胞移植与细胞治疗淋巴瘤

慢性移植物抗宿主病患者B细胞中异常的NOTCH2-BCR信号轴

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
PubMed 文献 · Blood · 2017-08-29

研究对30例造血干细胞移植后伴或不伴慢性移植物抗宿主病(cGVHD)患者的原代样本进行离体激活与信号检测,发现BCR-NOTCH激活显著增加近端BCR衔接蛋白BLNK并维持NOTCH2表面表达,特异性阻断NOTCH2可消除该激活;全反式维甲酸(ATRA)可提高IRF4表达、恢复IRF4与IRF8比值、消除BCR-NOTCH过度激活并降低NOTCH2表达而不影响活力。

要点

  • BCR-NOTCH激活显著增加近端BCR衔接蛋白BLNK,并维持NOTCH2表面表达,提示正反馈环路。
  • 特异性NOTCH2阻断消除NOTCH-BCR激活,显著改变NOTCH下游靶点及B细胞成熟/效应分子。
  • ATRA提高IRF4表达、恢复IRF4与IRF8比值、消除BCR-NOTCH过度激活并降低NOTCH2表达,不损害活力。

核心结论

  • 研究揭示NOTCH2激活与B细胞对低于最佳量的替代抗原产生强烈BCR反应之间的机制联系。
  • 作者认为cGVHD患者的外周B细胞可通过药物从过度激活转向成熟。

研究设计与样本

  • 离体激活与信号检测实验,纳入30例造血干细胞移植后伴或不伴cGVHD患者的原代样本。

主要发现

  • BCR-NOTCH激活显著增加近端BCR衔接蛋白BLNK。
  • BCR-NOTCH激活使NOTCH2表面表达持续存在,提示正反馈环路。
  • 特异性NOTCH2阻断消除NOTCH-BCR激活,并显著改变NOTCH下游靶点及B细胞成熟/效应分子。
  • cGVHD中NOTCH2-BCR轴的分子基础包括转录因子IRF4与IRF8表达失衡。
  • ATRA提高IRF4表达、恢复IRF4与IRF8比值、消除BCR-NOTCH过度激活并降低NOTCH2表达,不损害活力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

B-cell receptor (BCR)-activated B cells contribute to pathogenesis in chronic graft-versus-host disease (cGVHD), a condition manifested by both B-cell autoreactivity and immune deficiency. We hypothesized that constitutive BCR activation precluded functional B-cell maturation in cGVHD. To address this, we examined BCR-NOTCH2 synergy because NOTCH has been shown to increase BCR responsiveness in normal mouse B cells. We conducted ex vivo activation and signaling assays of 30 primary samples from hematopoietic stem cell transplantation patients with and without cGVHD. Consistent with a molecular link between pathways, we found that BCR-NOTCH activation significantly increased the proximal BCR adapter protein BLNK. BCR-NOTCH activation also enabled persistent NOTCH2 surface expression, suggesting a positive feedback loop. Specific NOTCH2 blockade eliminated NOTCH-BCR activation and significantly altered NOTCH downstream targets and B-cell maturation/effector molecules. Examination of the molecular underpinnings of this "NOTCH2-BCR axis" in cGVHD revealed imbalanced expression of the transcription factors IRF4 and IRF8, each critical to B-cell differentiation and fate. All-trans retinoic acid (ATRA) increased IRF4 expression, restored the IRF4-to-IRF8 ratio, abrogated BCR-NOTCH hyperactivation, and reduced NOTCH2 expression in cGVHD B cells without compromising viability. ATRA-treated cGVHD B cells had elevated TLR9 and PAX5, but not BLIMP1 (a gene-expression pattern associated with mature follicular B cells) and also attained increased cytosine guanine dinucleotide responsiveness. Together, we reveal a mechanistic link between NOTCH2 activation and robust BCR responses to otherwise suboptimal amounts of surrogate antigen. Our findings suggest that peripheral B cells in cGVHD patients can be pharmacologically directed from hyperactivation toward maturity.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Poe JC, Jia W, Su H, et al. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. Blood. 2017. PMID: 28851699. doi:10.1182/blood-2017-05-782466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。